Biohaven Ltd.
BHVN · XNYSCIK 1935979fmd_1AXR5ZGESEZVCD9VJX4S2XARAKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 24 periods
Latest annual · FY2025
Millions- Operating income
- (745)
- Net income
- (739)
- Free cash flow
- (610)
Latest quarter · Q3 FY2026
Millions- Operating income
- (126)
- Net income
- (129)
- Free cash flow
- (107)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Biohaven Ltd. (BHVN) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$745.4 million | -$885.1 million | 10-K 2026-03-02 · proof | |
| Net income | -$738.8 million | -$846.4 million | 10-K 2026-03-02 · proof | |
| Cash from operating activities | -$609.4 million | -$582.5 million | 10-K 2026-03-02 · proof | |
| Free cash flow | -$610.2 million | -$586.5 million | 10-K 2026-03-02 · proof | |
| Total assets | $451.4 million | $615.1 million | -26.6% | 10-K 2026-03-02 · proof |
| Total liabilities | $399.4 million | $191.7 million | +108.4% | 10-K 2026-03-02 · proof |
| Cash and cash equivalents | $230 million | $99.1 million | +132% | 10-K 2026-03-02 · proof |
- What was Biohaven Ltd. (BHVN)'s operating income in fiscal 2025?
- Biohaven Ltd. (BHVN) reported operating income of -$745.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$885.1 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What was Biohaven Ltd. (BHVN)'s net income in fiscal 2025?
- Biohaven Ltd. (BHVN) reported net income of -$738.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$846.4 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What was Biohaven Ltd. (BHVN)'s cash from operating activities in fiscal 2025?
- Biohaven Ltd. (BHVN) reported cash from operating activities of -$609.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$582.5 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What was Biohaven Ltd. (BHVN)'s free cash flow in fiscal 2025?
- Biohaven Ltd. (BHVN) reported free cash flow of -$610.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$586.5 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What are Biohaven Ltd. (BHVN)'s total assets?
- As of Dec 31, 2025, Biohaven Ltd. (BHVN) reported total assets of $451.4 million, against $615.1 million a year earlier (-26.6%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What are Biohaven Ltd. (BHVN)'s total liabilities?
- As of Dec 31, 2025, Biohaven Ltd. (BHVN) reported total liabilities of $399.4 million, against $191.7 million a year earlier (+108.4%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
- What are Biohaven Ltd. (BHVN)'s cash and cash equivalents?
- As of Dec 31, 2025, Biohaven Ltd. (BHVN) reported cash and cash equivalents of $230 million, against $99.1 million a year earlier (+132%). Source: the 10-K filed with the SEC on Mar 2, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BHVN&period_type=annual&limit=5"Information only, not investment advice.